HIGHLIGHTS
- Who: Posted Date April and colleagues from the (UNIVERSITY) have published the article: Low Rates of Vaccination Among Atopic Dermatitis, Alopecia Areata, Psoriasis, and Psoriatic Arthritis Patients on Biologics, in the Journal: (JOURNAL)
SUMMARY
Injectable biologics and oral Janus kinase (JAK) inhibitors have revolutionized the treatment of several inflammatory diseases, with USA Federal Drug Administration (FDA) approval in atopic dermatitis (AD), psoriasis (PSO), psoriatic arthritis (PsA), and alopecia areata (AA). Unlike the general population, for which the pneumococcal vaccine is recommended in adults ≥ 65years-old and the herpes zoster vaccine is recommended for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.